ArticleActive
Response to Comments: MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer (L38443)
A58117
Wisconsin Physicians Service Insurance Corporation (J05)
Effective: June 14, 2020
Updated: December 31, 2025
See LCD L38443Policy Summary
This administrative notice (A58117) records the response to comments for MolDX Local Coverage Determination L38443 covering predictive classifiers for early-stage non-small cell lung cancer. No provider comments were received; the notice period began 2020-04-30 and the LCD became effective 2020-06-14, and the LCD title was changed from "Razor 14-Gene Lung Cancer Assay" to "Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer."